Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (411-420 of 2,160) with videos related to

Pageof 216
Sort By:
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Expert Review of Cardiovascular Therapy|September 16, 2014
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomesGiuseppe Gargiulo, Davide Capodanno, Giovanni Longo, et al.
Revista Espanola De Cardiologia (English Ed.)|February 21, 2023
Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trialsGiovanni Occhipinti, Claudio Laudani, Marco Spagnolo, et al.
European Heart Journal. Case Reports|November 12, 2024
A rare complication of blood culture-negative infective endocarditis on tricuspid valve: case reportGiovanni Bellina, Salvatore Scandura, Salvatore Lentini, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: 40 years of percutaneous cardiac interventionRobert A Byrne, Davide Capodanno, Darren Mylotte, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 1, 2024
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular MedicineMarco Spagnolo, Claudio Laudani, Antonio Greco, et al.
ESC Heart Failure|June 30, 2026
Achalasia-induced reversible sinus node dysfunction in DSP/TNNI3 cardiomyopathy: an extracardiac cause of sinus pauses mimicking progression of genetic cardiomyopathyLuigi Cutore, Giuseppe Valadà, Giuseppe Leonardi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Lessons from the GHOST-EU registryAzeem Latib, Davide Capodanno, Maciej Lesiak, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Reply: Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) RegistrySalvatore Geraci, Hiroyoshi Kawamoto, Davide Capodanno, et al.
Pageof 216

Showing results (411-420 of 2,160) with videos related to

Sort By:
Pageof 216
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Expert Review of Cardiovascular Therapy|September 16, 2014
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomesGiuseppe Gargiulo, Davide Capodanno, Giovanni Longo, et al.
Revista Espanola De Cardiologia (English Ed.)|February 21, 2023
Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trialsGiovanni Occhipinti, Claudio Laudani, Marco Spagnolo, et al.
European Heart Journal. Case Reports|November 12, 2024
A rare complication of blood culture-negative infective endocarditis on tricuspid valve: case reportGiovanni Bellina, Salvatore Scandura, Salvatore Lentini, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: 40 years of percutaneous cardiac interventionRobert A Byrne, Davide Capodanno, Darren Mylotte, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 1, 2024
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular MedicineMarco Spagnolo, Claudio Laudani, Antonio Greco, et al.
ESC Heart Failure|June 30, 2026
Achalasia-induced reversible sinus node dysfunction in DSP/TNNI3 cardiomyopathy: an extracardiac cause of sinus pauses mimicking progression of genetic cardiomyopathyLuigi Cutore, Giuseppe Valadà, Giuseppe Leonardi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Lessons from the GHOST-EU registryAzeem Latib, Davide Capodanno, Maciej Lesiak, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Reply: Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) RegistrySalvatore Geraci, Hiroyoshi Kawamoto, Davide Capodanno, et al.
Pageof 216